High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
Apolipoprotein A-I (apoA-I) and high-density lipoproteins (HDL) mediate reverse cholesterol transport out of cells. Furthermore, HDL has additional protective functions, which include anti-oxidative, anti-inflammatory, anti-apoptotic, and vasoprotective effects. In contrast, HDL can become dysfunc...
Main Authors: | Elizabeth M. Gordon, Debbie M. Figueroa, Amisha V. Barochia, Xianglan Yao, Stewart J. Levine |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00323/full |
Similar Items
-
High-density lipoprotein, and apolipoprotein A-I: a regulatory role and novel therapeutic strategies for the treatment atherosclerosis
by: L. M. Polyakov, et al.
Published: (2013-03-01) -
The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
by: A. M. Kaneva, et al.
Published: (2018-06-01) -
The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Dustin Chernick, et al.
Published: (2020-09-01) -
Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01) -
Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis
by: Juan R. Ulloque-Badaracco, et al.
Published: (2023-07-01)